Ronald J Korthuis Selected Research

Stroke (Strokes)

1/2012	Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms.
5/2006	Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald J Korthuis Research Topics

Disease

28	Ischemia 01/2021 - 09/2002
9	Inflammation (Inflammations) 01/2020 - 06/2007
4	Brain Ischemia (Cerebral Ischemia) 08/2010 - 05/2006
3	Reperfusion Injury 01/2021 - 10/2010
3	Hypertension (High Blood Pressure) 01/2011 - 06/2007
2	Atherosclerosis 10/2020 - 01/2011
2	Sepsis (Septicemia) 01/2020 - 01/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 01/2012
2	Stroke (Strokes) 01/2012 - 05/2006
1	Carcinoma (Carcinomatosis) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Hyperlipidemias (Hyperlipidemia) 10/2020
1	Acute Lung Injury 01/2020
1	Lung Injury 01/2020
1	Hemorrhagic Shock 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Myocardial Infarction 01/2012
1	Rupture 01/2012
1	Binge Drinking 01/2012
1	Ischemic Stroke 01/2012
1	Asthma (Bronchial Asthma) 01/2011
1	Hypersensitivity (Allergy) 01/2011
1	Arthritis (Polyarthritis) 01/2011
1	Abdominal Aortic Aneurysm 01/2011
1	Body Weight (Weight, Body) 05/2006

Drug/Important Bio-Agent (IBA)

9	Ethanol (Ethyl Alcohol)IBA 01/2012 - 09/2002
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
5	Heme Oxygenase-1IBA 11/2017 - 11/2005
3	Peroxidase (Myeloperoxidase)IBA 01/2020 - 01/2012
3	CalciumIBA 12/2016 - 01/2012
3	sodium bisulfide (NaHS)IBA 01/2012 - 11/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2011 - 01/2007
3	salicylhydroxamic acid (SHAM)IBA 04/2011 - 12/2004
2	Plasminogen Activator Inhibitor 1IBA 01/2021 - 01/2018
2	LipidsIBA 01/2020 - 01/2019
2	Oxidants (Oxidizing Agents)IBA 11/2017 - 04/2003
2	Adenosine Triphosphatases (ATPase)IBA 12/2016 - 01/2012
2	Soluble Guanylyl CyclaseIBA 01/2016 - 08/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014 - 05/2006
2	Adenosine (Adenocard)FDA LinkGeneric 01/2014 - 03/2007
2	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2012 - 09/2011
2	AICA ribonucleotide (ZMP)IBA 04/2011 - 02/2009
2	erucylphosphocholineIBA 04/2011 - 03/2007
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2011 - 02/2009
2	PolyphenolsIBA 05/2009 - 04/2003
2	acetovanillone (apocynin)IBA 10/2007 - 05/2006
2	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2007 - 05/2006
2	Nitric Oxide Synthase (NO Synthase)IBA 03/2007 - 01/2007
2	P-SelectinIBA 04/2005 - 12/2004
1	Caveolin 2IBA 01/2021
1	ApolipoproteinsIBA 10/2020
1	Apolipoproteins E (ApoE)IBA 10/2020
1	Insulin (Novolin)FDA Link 10/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 10/2020
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 10/2020
1	Tight Junction ProteinsIBA 10/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	N-acetyllysyltyrosylcysteine amideIBA 01/2020
1	HydrazinesIBA 01/2020
1	Mast Cell StabilizersIBA 01/2020
1	ChemokinesIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	AldehydesIBA 01/2020
1	CytokinesIBA 01/2020
1	4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA 01/2020
1	ChloridesIBA 01/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2019
1	Vasoconstrictor AgentsIBA 01/2019
1	Vasodilator Agents (Vasodilators)IBA 01/2019
1	NS 1619IBA 11/2017
1	4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acidIBA 01/2016
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2016
1	NitratesIBA 08/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2012
1	PotassiumIBA 01/2012
1	Adenosine Triphosphate (ATP)IBA 01/2012
1	Peptide Hydrolases (Proteases)FDA Link 01/2011
1	serglycinIBA 01/2011
1	Proteoglycans (Proteoglycan)IBA 01/2011
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 11/2010
1	ApaminIBA 11/2010
1	paxillineIBA 11/2010
1	TRAM 34IBA 11/2010
1	AntioxidantsIBA 10/2010
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 08/2010
1	Matrix Metalloproteinases (MMPs)IBA 07/2010
1	EndotoxinsIBA 02/2009
1	Amyloid beta-PeptidesIBA 02/2009
1	AMP-Activated Protein KinasesIBA 02/2009
1	Angiotensin IIIBA 06/2007
1	Neuroprotective AgentsIBA 05/2006
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 05/2006
1	Protein Kinase CIBA 04/2005
1	Monoclonal AntibodiesIBA 12/2004
1	Xanthine OxidaseIBA 04/2003
1	ResveratrolIBA 04/2003
1	HypoxanthineIBA 04/2003

Therapy/Procedure

1	Ligation 01/2020
1	Punctures 01/2020
1	Oral Administration 05/2009